Xin Lang Zheng Quan·2025-09-12 09:09Core Viewpoint - The skincare and daily chemical industry in A-share listed companies has shown significant performance divergence in the first half of 2025, with 6 companies experiencing both revenue and profit declines, while 6 others reported growth in both metrics, 1 company saw revenue growth without profit increase, and 1 company reported a loss [1][2]. Performance Summary - Among the 14 selected listed companies, 6 companies reported both revenue and profit declines: - Lafang Cosmetics: Revenue of 410 million, down 4.27%, net profit of 6 million, down 82.89% [2] - Furuida: Revenue of 1.79 billion, down 7.05%, net profit of 108 million, down 15.16% [2] - Fulejia: Revenue of 863 million, down 8.15%, net profit of 230 million, down 32.54% [2] - Beitaini: Revenue of 2.372 billion, down 15.43%, net profit of 247 million, down 49.01% [2] - Huaxi Biological: Revenue of 2.261 billion, down 19.57%, net profit of 221 million, down 35.38% [2] - Kesi Co.: Revenue of 721 million, down 48.67%, net profit of 65 million, down 84.51% [2] - One company, Chuang'er Biological, reported revenue growth of 16.98% to 214 million but a net profit decline of 55.99% to 13 million [3][4]. - One company, Jiaheng Cosmetics, reported revenue of 514 million, up 21.72%, but a net loss of 32 million, with losses significantly widening [5][6]. The loss was attributed to increased operational costs and fixed expenses related to its Huzhou base [5]. Industry Challenges - Lafang Cosmetics faced significant pressure from changing domestic and international operating environments, leading to increased sales and financial expenses despite a revenue decline [6].